Clinical trial
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
NCT02187549 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2014
- Completion date
- March 31, 2016
- Enrollment
- 332 (estimated)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis